3 studies found for:    9166827 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Condition: Follicular Lymphoma
Intervention: Drug: BeEAM
2 Completed Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma
Conditions: Lymphoma;   Diffuse Large Cell
Intervention: Procedure: Blood draw
3 Active, not recruiting Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas
Conditions: Lymphoma, T-Cell;   Lymphoma, Extranodal NK-T-Cell
Interventions: Biological: Alemtuzumab (Campath);   Drug: EPOCH

Indicates status has not been verified in more than two years